Correction: The application of CRISPR/Cas9 system in cervical carcinogenesis

Cancer Gene Ther. 2022 May;29(5):625-626. doi: 10.1038/s41417-021-00393-7.

Chun Gao^#^{1

2}, Ping Wu^#^{1

2}, Lan Yu^#³, Liting Liu¹, Hong Liu¹, Xiangyu Tan¹, Liming Wang^{1

2}, Xiaoyuan Huang^{4

5}, Hui Wang^{6

7

8}

¹ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
² Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
³ Department of Gynecologic Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
⁴ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [email protected].
⁵ Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [email protected].
⁶ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [email protected].
⁷ Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [email protected].
⁸ Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China. [email protected].

^# Contributed equally.

No abstract available

Publication types